By Pushkala Aripaka, Bhanvi Satija and Maggie Fick LONDON, Feb 10 (Reuters) - AstraZeneca forecast steady profit growth in ...

AstraZeneca has reported a robust rise in revenue in 2025, driven by strong demand for its cancer medicines, and struck an ...

AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control ...

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division.

In 2026, an estimated 67,530 people will be diagnosed with pancreatic cancer, according to the American Cancer Society. But ...

British pharmaceutical giant AstraZeneca said Tuesday that its net profit jumped 45 percent last year on strong sales of cancer drugs, as it expands its reach in the United States and China. - China, ...

Shares edged 1% higher in morning trading on Tuesday, with the stock having risen 28% in the past six months.

Nova Scotia will be the first site in the world to test a potentially groundbreaking cancer treatment. Global pharmaceutical ...

AstraZeneca receives approval to market Imfinzi in India for advanced endometrial cancer treatment, enhancing therapeutic options.

Drug maker is boosting its product pipeline and investing in key markets as it strives to hit $80-billion in annual sales by ...

The National Cancer Institute is studying ivermectin as a potential cancer treatment, according to its top official, alarming career scientists.